Improving early phase oncology clinical trial design using Bayesian-based BOIN and BOP2 designs

Tim Clark, VP Drug Development Solutions, Martin Lachs, VP Project Management Oncology & Cell Therapeutics and Alan Phillips, Sr. Director Biostatistics, offer insights on selecting and implementing the appropriate model-based or model-assisted design for early phase oncology trials.